NO20073367L - Makrolider - Google Patents
MakroliderInfo
- Publication number
- NO20073367L NO20073367L NO20073367A NO20073367A NO20073367L NO 20073367 L NO20073367 L NO 20073367L NO 20073367 A NO20073367 A NO 20073367A NO 20073367 A NO20073367 A NO 20073367A NO 20073367 L NO20073367 L NO 20073367L
- Authority
- NO
- Norway
- Prior art keywords
- compounds
- methods
- macrolides
- intermediates
- antibacterial
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Tires In General (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US63809704P | 2004-12-21 | 2004-12-21 | |
US71753005P | 2005-09-14 | 2005-09-14 | |
PCT/IB2005/003829 WO2006067589A1 (fr) | 2004-12-21 | 2005-12-12 | Macrolides |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20073367L true NO20073367L (no) | 2007-09-05 |
Family
ID=35809765
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20073367A NO20073367L (no) | 2004-12-21 | 2007-06-29 | Makrolider |
Country Status (35)
Country | Link |
---|---|
US (1) | US7462600B2 (fr) |
EP (2) | EP2233493A1 (fr) |
JP (1) | JP4111994B1 (fr) |
KR (1) | KR100897678B1 (fr) |
CN (1) | CN101120011A (fr) |
AP (1) | AP2007004026A0 (fr) |
AR (1) | AR052824A1 (fr) |
AT (1) | ATE459633T1 (fr) |
AU (1) | AU2005317735B2 (fr) |
BR (1) | BRPI0519135A2 (fr) |
CA (1) | CA2591746A1 (fr) |
CR (1) | CR9202A (fr) |
DE (1) | DE602005019786D1 (fr) |
DK (1) | DK1836211T3 (fr) |
EA (1) | EA011281B1 (fr) |
ES (1) | ES2339871T3 (fr) |
GE (1) | GEP20094834B (fr) |
GT (1) | GT200500378A (fr) |
HN (1) | HN2005036113A (fr) |
HR (1) | HRP20100253T1 (fr) |
IL (1) | IL183661A0 (fr) |
MA (1) | MA29108B1 (fr) |
MX (1) | MX2007007598A (fr) |
NL (1) | NL1030713C2 (fr) |
NO (1) | NO20073367L (fr) |
PE (1) | PE20060948A1 (fr) |
PL (1) | PL1836211T3 (fr) |
PT (1) | PT1836211E (fr) |
SI (1) | SI1836211T1 (fr) |
TN (1) | TNSN07233A1 (fr) |
TW (1) | TW200626608A (fr) |
UA (1) | UA85937C2 (fr) |
UY (1) | UY29285A1 (fr) |
WO (1) | WO2006067589A1 (fr) |
ZA (1) | ZA200705108B (fr) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8367669B2 (en) * | 2005-06-15 | 2013-02-05 | Vanderbilt University | Inhibitors of hemeprotein-catalyzed lipid peroxidation |
US9133212B1 (en) | 2005-06-15 | 2015-09-15 | Vanderbilt University | Inhibitors of hemeprotein-catalyzed lipid peroxidation |
DK1934238T3 (en) | 2005-08-24 | 2017-09-18 | Melinta Therapeutics Inc | TRIAZOL COMPOUNDS AND METHODS FOR THE PREPARATION AND USE OF THESE |
EP2125851B1 (fr) * | 2007-03-13 | 2010-06-23 | Pfizer Products Inc. | Macrolides à base d'erythromycine |
EP2136806A4 (fr) * | 2007-03-21 | 2011-11-23 | Creative Antibiotics Sweden Ab | Procédé et moyens pour prévenir et inhiber une sécrétion de type iii dans des infections provoquées par une bactérie à gram-négatif |
JP5698979B2 (ja) | 2007-10-25 | 2015-04-08 | センプラ ファーマシューティカルズ,インコーポレイテッド | マクロライド系抗菌剤の調製プロセス |
EP2220104A1 (fr) * | 2007-10-25 | 2010-08-25 | Sandoz AG | Procédé de fabrication de télithromycine |
KR101610607B1 (ko) | 2007-12-21 | 2016-04-07 | 에프. 호프만-라 로슈 아게 | 헤테로사이클릭 항바이러스 화합물 |
CA2769551A1 (fr) | 2009-08-13 | 2011-02-17 | Basilea Pharmaceutica Ag | Nouveaux macrolides et leur utilisation |
EP3009442B1 (fr) * | 2010-03-22 | 2019-06-19 | Cempra Pharmaceuticals, Inc. | Formes cristallines d'un macrolide et leurs utilisations |
EP2696873B1 (fr) | 2011-04-12 | 2022-08-03 | The United States of America, as represented by The Secretary, Department of Health and Human Services | Inhibiteurs du canal anionique de surface de plasmodium pour le traitement ou la prévention de la malaria |
CN102558047B (zh) * | 2011-12-14 | 2013-10-30 | 天津药物研究院药业有限责任公司 | 3-甲基喹啉的制备方法 |
RU2658050C2 (ru) | 2012-03-27 | 2018-06-19 | Семпра Фармасьютикалз, Инк. | Парентеральные составы для введения макролидных антибиотиков |
CN104507913B (zh) | 2012-07-13 | 2017-07-28 | 霍夫曼-拉罗奇有限公司 | 抗增殖的苯并[b]氮杂*‑2‑酮 |
KR101612179B1 (ko) * | 2013-04-19 | 2016-04-12 | 영남대학교 산학협력단 | 아미도피리딘올 유도체 또는 이의 약제학적 허용가능한 염을 유효성분으로 함유하는 암질환 예방 또는 치료용 약학조성물 |
TW201534586A (zh) | 2013-06-11 | 2015-09-16 | Orion Corp | 新穎cyp17抑制劑/抗雄激素劑 |
CN103739643A (zh) * | 2013-12-30 | 2014-04-23 | 华东理工大学 | 利用分子印迹技术对红霉素进行回收分离纯化的方法 |
CN104230891B (zh) * | 2014-08-27 | 2016-03-30 | 于宗光 | 一种托匹司他的制备方法 |
EP3522896A4 (fr) * | 2016-10-04 | 2020-06-17 | Biopharmati SA | Cétolides à activité antibactrienne |
JP2022534709A (ja) * | 2019-06-04 | 2022-08-03 | ヘイガー バイオサイエンシズ,エルエルシー | オレキシンアンタゴニストとしてのピラゾール及びイミダゾール誘導体、組成物、並びに方法 |
CN111793022A (zh) * | 2020-04-27 | 2020-10-20 | 滁州拜奥生物科技有限公司 | 一种3-甲基喹啉的制备方法 |
WO2024050061A2 (fr) * | 2022-09-01 | 2024-03-07 | Hager Biosciences, Llc | Dérivés de pyrazole et d'imidazole utilisés en tant que modulateurs des récepteurs double d'orexine et d'opioïdes kappa, composition, procédés de traitement de troubles neurologiques et psychiatriques |
Family Cites Families (74)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2653899A (en) | 1952-04-14 | 1953-09-29 | Lilly Co Eli | Erythromycin, its salts, and method of preparation |
US2823203A (en) | 1954-06-24 | 1958-02-11 | Abbott Lab | Method of producing substantially pure erythromycin a |
US4331803A (en) | 1980-06-04 | 1982-05-25 | Taisho Pharmaceutical Co., Ltd. | Novel erythromycin compounds |
YU43006B (en) | 1981-03-06 | 1989-02-28 | Pliva Pharm & Chem Works | Process for preparing n-methyl-11-aza-10-deoxo-10-dihydro erythromycin and derivatives thereof |
US4474768A (en) | 1982-07-19 | 1984-10-02 | Pfizer Inc. | N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor |
US4742049A (en) * | 1986-06-04 | 1988-05-03 | Abbott Laboratories | Semisynthetic erythromycin antibiotics |
US5075289A (en) | 1988-06-07 | 1991-12-24 | Abbott Laboratories | 9-r-azacyclic erythromycin antibiotics |
IE70593B1 (en) | 1989-09-29 | 1996-12-11 | Eisai Co Ltd | Biphenylmethane derivative the use of it and pharmacological compositions containing same |
US5523399A (en) | 1991-12-27 | 1996-06-04 | Taisho Pharmaceutical Co., Ltd. | 5-O-desosaminylerythronolide derivatives |
US5527780A (en) | 1992-11-05 | 1996-06-18 | Roussel Uclaf | Erythromycin derivatives |
FR2697524B1 (fr) * | 1992-11-05 | 1994-12-23 | Roussel Uclaf | Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments. |
FR2719587B1 (fr) | 1994-05-03 | 1996-07-12 | Roussel Uclaf | Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments. |
US5629322A (en) | 1994-11-15 | 1997-05-13 | Merck & Co., Inc. | Cyclic amidine analogs as inhibitors of nitric oxide synthase |
FR2727969B1 (fr) * | 1994-12-09 | 1997-01-17 | Roussel Uclaf | Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments |
US5747466A (en) * | 1995-11-08 | 1998-05-05 | Abbott Laboratories | 3-deoxy-3-descladinose derivatives of erythromycins A and B |
FR2742757B1 (fr) | 1995-12-22 | 1998-01-30 | Roussel Uclaf | Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments |
EP0918783A1 (fr) * | 1996-05-07 | 1999-06-02 | Abbott Laboratories | Erythromycines 6-o substituees et leur procede de preparation |
US5750510A (en) * | 1997-04-04 | 1998-05-12 | Abbott Laboratories | 3-descladinose-2,3-anhydroerythromycin derivatives |
FR2748746B1 (fr) * | 1996-05-14 | 1998-08-14 | Hoechst Marion Roussel Inc | Nouveau procede d'isomerisation du radical methyle en 10 de derives de l'erythromycine |
US6271255B1 (en) | 1996-07-05 | 2001-08-07 | Biotica Technology Limited | Erythromycins and process for their preparation |
FR2751656B1 (fr) * | 1996-07-24 | 1998-10-16 | Hoechst Marion Roussel Inc | Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments |
CN100441591C (zh) | 1996-09-04 | 2008-12-10 | 艾博特公司 | 酮基内酯类化合物,其用途和制备方法以及药用组合物 |
US5804565A (en) | 1996-09-24 | 1998-09-08 | Taisho Pharmaceutical Co., Ltd. | Erythromycin A derivatives |
CZ180799A3 (cs) | 1996-11-27 | 1999-09-15 | Taisho Pharmaceutical Co., Ltd. | Deriváty erythromycinu A |
AU6421398A (en) | 1997-03-24 | 1998-10-20 | Taisho Pharmaceutical Co., Ltd. | Erythromycin a derivatives |
US6162794A (en) | 1997-05-09 | 2000-12-19 | Pfizer Inc. | Erythromycin derivatives |
US20020025937A1 (en) | 2000-03-20 | 2002-02-28 | Yong-Jin Wu | 9-oxime erythromycin derivatives |
EP0895999A1 (fr) * | 1997-08-06 | 1999-02-10 | Pfizer Products Inc. | Macrolides antibiotiques substitués C"-4 |
ZA987689B (en) | 1997-09-02 | 1999-02-24 | Abbott Lab | 3-descladinose 6-O substituted erythromycin derivatives |
US6034069A (en) * | 1997-09-30 | 2000-03-07 | Abbott Laboratories | 3-'N-modified 6-O-substituted erythromycin ketolide derivatives having antibacterial activity |
ZA989835B (en) | 1997-10-29 | 1999-05-05 | Taisho Pharmaceutical Co Ltd | Erythromycin a derivatives |
PA8461401A1 (es) | 1997-10-29 | 2000-05-24 | Pfizer Prod Inc | Derivados de eritromicina triciclicos |
HN1998000159A (es) | 1997-10-29 | 1999-02-09 | Monsanto Co | Derivados de 9- amino - 3 ceto eritromicina |
AP1060A (en) | 1998-01-02 | 2002-04-23 | Pfizer Prod Inc | Novel erythromycin derivatives. |
AP9801420A0 (en) | 1998-01-02 | 1998-12-31 | Pfizer Prod Inc | Novel macrolides. |
DE69919769T2 (de) | 1998-03-03 | 2005-01-27 | Pfizer Products Inc., Groton | 3,6-Ketal-Makrolidantibiotika |
US5955440A (en) * | 1998-03-27 | 1999-09-21 | Abbott Laboratories | Macrolide LHRH antagonists |
WO1999062920A1 (fr) | 1998-06-03 | 1999-12-09 | Pfizer Products Inc. | Derives 3-keto tricycliques de 6-o-methylerythromycine |
JP4573925B2 (ja) * | 1998-07-09 | 2010-11-04 | アベンティス・ファーマ・ソシエテ・アノニム | 新規のエリスロマイシン誘導体、その製造方法及びその薬剤としての使用 |
US6020521A (en) | 1998-08-26 | 2000-02-01 | Abbott Laboratories | Macrolide LHRH antagonists |
US6387885B1 (en) * | 1998-08-26 | 2002-05-14 | Abbott Laboratories | 3′,3′-N-bis-desmethyl-3′-N-cycloalkyl erythromycin derivatives as LHRH antagonists |
US6262030B1 (en) | 1998-11-03 | 2001-07-17 | Pfizer Inc. | Erythromycin derivatives |
KR20010083944A (ko) | 1998-11-03 | 2001-09-03 | 실버스타인 아써 에이. | 신규 마크롤라이드 항생물질 |
EP1137654A1 (fr) * | 1998-12-10 | 2001-10-04 | Pfizer Products Inc. | Antibiotiques a base de cetolides de carbamate et de carbazate |
SI1147121T1 (en) | 1999-01-27 | 2004-04-30 | Pfizer Products Inc. | Ketolide antibiotics |
US6054435A (en) * | 1999-03-19 | 2000-04-25 | Abbott Laboratories | 6-O-substituted macrolides having antibacterial activity |
US6399582B1 (en) * | 1999-04-16 | 2002-06-04 | Ortho-Mcneil Pharmaceutical, Inc. | Ketolide antibacterials |
MXPA01010524A (es) * | 1999-04-16 | 2002-03-14 | Kosan Biosciences Inc | Agentes macrolidos anti-infecciosos. |
US6939861B2 (en) | 1999-04-16 | 2005-09-06 | Kosan Biosciences, Inc. | Amido macrolides |
US20020061857A1 (en) | 1999-04-23 | 2002-05-23 | Yong-Jin Wu | 9-amino-3-oxo erythromycin derivatives |
US20020077302A1 (en) | 1999-04-23 | 2002-06-20 | Yong-Jin Wu | Tricyclic erythromycin derivatives |
US6355620B1 (en) * | 1999-05-14 | 2002-03-12 | Abbott Laboratories | C-2 modified erythromycin derivatives |
EE200100613A (et) | 1999-05-24 | 2003-02-17 | Pfizer Products Inc. | 13-metüülerütromütsiini derivaadid |
JP2001072669A (ja) | 1999-09-07 | 2001-03-21 | Showa Kako Kk | 7−クロロ−2,4(1h,3h)−キナゾリンジオンの製造方法 |
US6569836B2 (en) * | 1999-12-02 | 2003-05-27 | Abbott Laboratories | 6-O-alkyl-2-nor-2-substituted ketolide derivatives |
EP1114826A3 (fr) | 1999-12-29 | 2001-10-31 | Pfizer Products Inc. | Macrolides antibactériennes et prokinétiques |
EP1122261A3 (fr) | 2000-01-31 | 2001-09-26 | Pfizer Products Inc. | Macrolides antibactériennes à 13 ou 14 chainons |
JP2001261694A (ja) | 2000-03-06 | 2001-09-26 | Pfizer Prod Inc | ケトライド抗生物質 |
EP1146051A3 (fr) | 2000-04-10 | 2001-10-31 | Pfizer Products Inc. | Dérivées de l' érythromycine A |
US20020061856A1 (en) | 2000-04-24 | 2002-05-23 | Yong-Jin Wu | Novel tricyclic erythromycin derivatives |
TR200401847T4 (tr) | 2000-06-30 | 2004-09-21 | Pfizer Products Inc. | Makrolit antibiyotikler. |
US20020115621A1 (en) | 2000-08-07 | 2002-08-22 | Wei-Gu Su | Macrolide antibiotics |
HUP0302526A2 (hu) | 2000-12-21 | 2003-11-28 | Glaxo Group Limited | Makrolid vegyületek, eljárás az előállításukra, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények |
US20020132782A1 (en) * | 2001-01-18 | 2002-09-19 | Zhenkun Ma | 9-amino erythromycin derivatives with antibacterial activity |
CA2451391A1 (fr) * | 2001-07-03 | 2003-01-16 | Chiron Corporation | Macrolides et cetolides d'erythromycine modifiee c12 a activite antibacterienne |
US7064110B2 (en) | 2002-05-13 | 2006-06-20 | Enanta Pharmaceuticals, Inc. | 6-11 bicycle ketolide derivatives |
WO2005070918A1 (fr) | 2002-05-13 | 2005-08-04 | Enanta Pharmaceuticals, Inc. | Procede de preparation de derives bicycliques 6-11 d'erythromycine |
PL378841A1 (pl) | 2003-04-21 | 2006-05-29 | Daiichi Pharmaceutical Co., Ltd. | Pochodna pięcioczłonowego układu heterocyklicznego |
US20080287376A1 (en) | 2004-07-28 | 2008-11-20 | Mohammad Salman | Ketolide Derivatives as Antibacterial Agents |
US20090170790A1 (en) | 2004-10-25 | 2009-07-02 | Biswajit Das | Ketolide derivatives as antibacterial agents |
GB0424951D0 (en) | 2004-11-11 | 2004-12-15 | Glaxo Group Ltd | Novel compounds |
JP2008522978A (ja) | 2004-12-07 | 2008-07-03 | エナンタ ファーマシューティカルズ インコーポレイテッド | 3,6−ビシクロライド |
US7312201B2 (en) | 2004-12-13 | 2007-12-25 | Enanta Pharmaceuticals, Inc. | Tetracyclic bicyclolides |
WO2006065721A2 (fr) | 2004-12-13 | 2006-06-22 | Enanta Pharmaceuticals, Inc. | Bicyclolides de 11, 12-lactone |
-
2005
- 2005-12-12 AP AP2007004026A patent/AP2007004026A0/xx unknown
- 2005-12-12 WO PCT/IB2005/003829 patent/WO2006067589A1/fr active Application Filing
- 2005-12-12 JP JP2007547694A patent/JP4111994B1/ja not_active Expired - Fee Related
- 2005-12-12 EP EP10154783A patent/EP2233493A1/fr not_active Withdrawn
- 2005-12-12 AT AT05813939T patent/ATE459633T1/de not_active IP Right Cessation
- 2005-12-12 EA EA200701113A patent/EA011281B1/ru not_active IP Right Cessation
- 2005-12-12 BR BRPI0519135-1A patent/BRPI0519135A2/pt not_active IP Right Cessation
- 2005-12-12 SI SI200530941T patent/SI1836211T1/sl unknown
- 2005-12-12 DE DE602005019786T patent/DE602005019786D1/de active Active
- 2005-12-12 AU AU2005317735A patent/AU2005317735B2/en not_active Ceased
- 2005-12-12 PL PL05813939T patent/PL1836211T3/pl unknown
- 2005-12-12 DK DK05813939.5T patent/DK1836211T3/da active
- 2005-12-12 EP EP05813939A patent/EP1836211B1/fr active Active
- 2005-12-12 ES ES05813939T patent/ES2339871T3/es active Active
- 2005-12-12 GE GEAP200510142A patent/GEP20094834B/en unknown
- 2005-12-12 KR KR1020077014160A patent/KR100897678B1/ko not_active IP Right Cessation
- 2005-12-12 PT PT05813939T patent/PT1836211E/pt unknown
- 2005-12-12 CA CA002591746A patent/CA2591746A1/fr not_active Abandoned
- 2005-12-12 MX MX2007007598A patent/MX2007007598A/es active IP Right Grant
- 2005-12-12 UA UAA200706959A patent/UA85937C2/uk unknown
- 2005-12-12 CN CNA2005800482465A patent/CN101120011A/zh active Pending
- 2005-12-14 PE PE2005001462A patent/PE20060948A1/es not_active Application Discontinuation
- 2005-12-19 HN HN2005036113A patent/HN2005036113A/es unknown
- 2005-12-20 AR ARP050105370A patent/AR052824A1/es unknown
- 2005-12-20 GT GT200500378A patent/GT200500378A/es unknown
- 2005-12-20 TW TW094145385A patent/TW200626608A/zh unknown
- 2005-12-20 NL NL1030713A patent/NL1030713C2/nl not_active IP Right Cessation
- 2005-12-21 UY UY29285A patent/UY29285A1/es not_active Application Discontinuation
- 2005-12-21 US US11/313,523 patent/US7462600B2/en not_active Expired - Fee Related
-
2007
- 2007-06-04 IL IL183661A patent/IL183661A0/en unknown
- 2007-06-15 ZA ZA200705108A patent/ZA200705108B/xx unknown
- 2007-06-20 TN TNP2007000233A patent/TNSN07233A1/fr unknown
- 2007-06-21 MA MA30024A patent/MA29108B1/fr unknown
- 2007-06-21 CR CR9202A patent/CR9202A/es not_active Application Discontinuation
- 2007-06-29 NO NO20073367A patent/NO20073367L/no not_active Application Discontinuation
-
2010
- 2010-05-04 HR HR20100253T patent/HRP20100253T1/hr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20073367L (no) | Makrolider | |
NO20070566L (no) | Azin-karboksamider som antikreftmiddel | |
NO20073719L (no) | Kjemiske forbindelser | |
NO20070199L (no) | Substituerte kinazoloner som anti-kreftmidler | |
NO20056192L (no) | Kapaseinhibitorer og anvendelse derav | |
NO20082124L (no) | Bifenyloksyeddiksyrederivater for behandling av respiratorisk sykdom | |
NO20074703L (no) | Antibakterielle piperidinderivater | |
WO2007044085A3 (fr) | Composes heteroaryle et leurs utilisations en tant qu'agents therapeutiques | |
NO20070224L (no) | 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav | |
NO20081729L (no) | Nye diazaspiroalkaner og deres anvendelse for behandling av CCR8-medierte sykdommer | |
NO20080338L (no) | Forbindelser for behandling av multilegemiddelresistente bakterielle infeksjoner | |
NO20081844L (no) | Terapeutiske forbindelser | |
NO20082538L (no) | Stabiliserte lantankarbonatsammensetninger | |
NO20091605L (no) | Pyridinonforbindelser | |
WO2007046867A3 (fr) | Derives de piperidine et leurs utilisations comme agents therapeutiques | |
BRPI0517567A (pt) | composto ou um sal, solvato, ou derivado fisiologicamente funcional farmaceuticamente aceitável do mesmo, composição farmacêutica, usos de um composto ou um sal, solvato, ou derivado fisiologicamente funcional farmaceuticamente aceitável do mesmo e de uma composição farmacêutica, e, processo para preparar um composto | |
NO20061743L (no) | Kinazolinderivater | |
NO20076675L (no) | Aminopiperidinquinoliner og deres azaisosteriske analoger med antibakteriell aktivitet | |
NO20076019L (no) | Utvortes preparat for hud | |
NO20091683L (no) | Kjemiske forbindelser | |
NO20070487L (no) | 3-aminocyklopentankarboksamider som modulatorer av kjemokinreseptorer. | |
WO2007009724A3 (fr) | Derives de pyrazoline substitues cycloalkane, fabrication et utilisation comme medicaments | |
MX2007011009A (es) | Compuestos de piperidina 3,4,5-substituidos. | |
WO2006096444A3 (fr) | Composes chimiques | |
DE60206911D1 (de) | Imidazol-2-carbonsäureamid derivate als raf-kinase-inhibitoren |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |